• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

A project of clinical application in a gene therapy for chronic granulomatous disease with gp91-phox deficiency

Research Project

Project/Area Number 12557069
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section展開研究
Research Field Pediatrics
Research InstitutionMiyazaki Medical College (2001-2002)
Kumamoto University (2000)

Principal Investigator

NUNOI Hiroyuki  Miyazaki Medical College, Pediatrics, Professor, 医学部, 教授 (50218260)

Project Period (FY) 2000 – 2002
Project Status Completed (Fiscal Year 2002)
Budget Amount *help
¥12,800,000 (Direct Cost: ¥12,800,000)
Fiscal Year 2002: ¥3,200,000 (Direct Cost: ¥3,200,000)
Fiscal Year 2001: ¥4,000,000 (Direct Cost: ¥4,000,000)
Fiscal Year 2000: ¥5,600,000 (Direct Cost: ¥5,600,000)
KeywordsChronic granulomatous disease / gene therapy / p40-phox / Nox family / p41nox / p51nox / 遺伝子解析 / 病型分類 / インターフェロンγ / 遺伝子治療 / gp91-phox / MND-gp91-phox遺伝子治療ベクター / MFGS-gp91ベクター / gp91ノックアウト・マウス
Research Abstract

Clinical gene therapy was required more fundamental and clinical evidences for safety since 3-lymopoproliferative disease had been reported in A. Fischer's gene therapy protocol for X-SCID patients. More than 200 patients with chronic granulomatous disease (CGD) were first analyzed and a genetic mechanisms of IFN-gamma responsibility was analyzed in the patients with the splice mutation of gp91-phox deficiency (Blood 98 : 436-441, 2001).
In our 3-year's project, collaborating with Dr. Sugimoto, we constructed a bicistronic retrovirus vector, Ha-MDR-IRES-gp91, for the co-expression of MDR1 and gp91, a gene responsible for X-linked chronic granulomatous disease (X-CGD). Epstein-Barr virus-transformed B cells from X-CGD patients and human CD34-positive cells from an X-CGD patient transduced with Ha-MDR-IRES-gp91 co-expressed P-glycoprotein and gp91, and acquired superoxide-generating activity. Mice transplanted with Ha-MDR-IRES-gp91-transduced bone marrow cells showed co-expression of P-gl … More ycoprotein and gp91 in peripheral blood mononuclear cells. After repeatedly administration of paclitaxel, the ratio of P-glycoprotein- and gp91-positive cells were maintained for over 1 year. These results suggest that co-expression of a human multidrug resistance gene (MDR1) with a therapeutic gene affords selectable growth advantage to genetically modified cells (J Gene Med vol. 4, 2003).
In a collaboration with Dr. Sumimoto, we clarified the fourth cytosolic factor p40 (phox) participates in activation of the phagocyte oxidase by regulating membrane recruitment of p67 (phox) and p47 (phox) via the PB1-PC interaction with p67 (phox). (EMBO J 2002 Dec 2 ; 21(23) : 6312-20). In addition, we cloned human cDNAs for novel proteins homologous to p47phox and p67phox, designated p41nox and p51nox, respectively. Based on the combination studies, we found that the novel homologues p41nox and p51nox likely function together or in combination with a classical one, thereby activating the two Nox family oxidases (J Biol Chem 2003 in press). Less

Report

(4 results)
  • 2002 Annual Research Report   Final Research Report Summary
  • 2001 Annual Research Report
  • 2000 Annual Research Report
  • Research Products

    (33 results)

All Other

All Publications (33 results)

  • [Publications] Takeya R, Ueno N, Kami K, Taura M, Kojima M, Izaki T, Nunoi H, Sumimoto H.: "Novel human homologues of p47phox and p67phox participate in activation of superoxide-producing NADPH oxidases"J Biol Chem. (equb ahead of print). (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Yoshikazu Sugimoto, Satomi Tsukahara, Shigeo Sato, Mutsumi Suzuki, Hiroyuki Nunoi, Harry L.Melech, Michael M.Gottesman, Takhashi Tsuruo: "Drug-selected co-expression of P-glycoprotien and gp91 in vivo from an MDR1-bicistronic retrovirus vector Ha-MDR-IRES-gp91"Journal of Gene Medicine. 4・(in Press). (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] 布井博幸, 林摩耶, 早見典子, 原田優, 林幹夫, 広瀬真次, 松本栄悠, 水間洋, 日高文郎, 外山誠也, 水上智之: "小児免疫不全"臨床と研究. 79巻8号. 1404-1410 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Kuribayashi F, Nunoi H, Wakamatsu K, Tsunawaki S, Sato K, Ito T, Sumimoto H: "The adaptor protein p40(phox) as a positive regulator of the superoxide-producing phagocyte oxidase"The EMBO Journal. 21・23. 6312-6320 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Ishibashi F, Mizukami T, Kanegasaki S, Motoda L, Kakinuma R, Endo F, Nunoi N.: "Improved superoxide generating ability by interferon-gamma due to splicing pattern change of transcripts in neutrophils from patients with a splice site mutation in CYBB"Blood. 98・2. 436-441 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Nunoi H, Yamazaki T, Kanegasaki S: "Neutrophil cytoskeletal disease"Int J Hematol. 74・2. 119-124 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Cui SH, Tanabe F, Terunuma H, Iwatani Y, Nunoi H, Agematsu K, Komiyama A, Nomura A, Hara T, Onodera T, Iwata T, Ito M.: "A thiol proteinase inhibitor, E-64-d, corrects the abnormalities in concanavalin A cap formation and the lysosomal enzyme activity in leucocytes from patients with Chediak-Higashi syndrome by reversing the down-regulated protein kinase C activity"Clin Exp Immunol. 125・2. 283-290 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Ymauchi A, Yu L, Potgens AJ, Kuribayashi F, Nunoi H, Kanegasaki S, Roos D, Malech HL, Dinauer MC, Nakamura M.: "Location of the epitope for 7D5, a monoclonal antibody raised against human flavocytochrome b558, to the extracellular peptide portion of primate gp91phox"Microbiol Immunol. 43・3. 249-257 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] 岩田真由美, 布井博幸: "食細胞機能異常症"小児内科. 33巻増刊号. 250-251 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Ishibashi F., Nunoi H., Endo F., Matsuda I., Kanegasaki S.: "Statistical and mutational analysis of chronic granulomatous disease in Japan with special reference to gp91-phox and p22-phox deficiency"Human Genetics. 106・5. 473-481 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Takeya R, Ueno N, Kami K, Taura M, Kohjima M, Izaki T, Nunoi H, Sumimoto H: "Novel human homologues of p47phox and p67phox participate in activation of superoxide-producing NADPH oxidases."J Biol Chem. (epub ahead of print). (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Sugimoto Y, Tsukahara S, Sato S, Suzuki M, Nunoi H, Harry L. Malech, Michael M. Gottesman, and Takahashi Tsuruo: "Drug-selected co-expression of P-glycoprotein and gp91 in vivo from an MDR1-bicistronic retrovirus vector Ha-MDR-IRES-gp91."Journal of Gene Medicine. 4(in press). (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Nunoi H, Hayashi M, Hayami N, Harada S, Hayashi M, Hirose S, Matsumoto Y, Mizuma H, Hidaka F, Toyama S, Mizukami T: "Pediatric Immunodeficiency."Rrinshou to Kenkyu. 79(8). 1404-1410 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Kuribayashi F, Nunoi H, Wakamatsu K, Tsunawaki S, Sato K, Ito T, Sumimoto H: "The adaptor protein p40 (phox) as a positive regulator of the superoxide-producing phagocyte oxidase."The EMBO Journal. 21(23). 6312-6320 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Ishibashi F, Mizukami T, Kanegasaki S, Motoda L, Kakinuma R, Endo F, Nunoi N: "Improved superoxide generating ability by interferon-gamma due to splicing pattern change of transcripts in neutrophils from patients with a splice site mutation in CYBB gene."Blood. 98(2). 436-441 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Nunoi H. Yamazaki T, Kanegasaki S.: "Neutrophil cytoskeletal disease."Int J Hematol.. 74(2). 119-124 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Cui SH, Tanabe F, Terunuma H, Iwatani Y, Nunoi H. Agematsu K, Komiyama A, Nomura A, Hara T, Onodera T, Iwata T, Ito M: "A thiol proteinase inhibitor, E-64-d, corrects the abnormalities in concanavalin A cap formation and the lysosomal enzyme activity in leucocytes from patients with Chediak-Higashi syndrome by reversing the down-regulated protein kinase C activity."Clin Exp Immunol.. 125(2). 283-290 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Yamauchi A, Yu L, Potgens AJ, Kuribayashi F, Nunoi H, Kanegasaki S, Roos D, Malech HL, Dinauer MC, Nakamura M: "Location of the epitope for 7D5, a monoclonal antibody raised against human flavocytochrome b558, to the extracellular peptide portion of primate gp91phox."Microbiol Immunol.. 45(3). 249-257 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Iwata M, Nunoi H: "Shokusaibou Kinou Ijou."Shouni Naika. 33. 250-251 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Ishibashi F., Nunoi H., Endo F., Matsuda I., Kanegasaki S.: "Statistical and mutational analysis of chronic granulomatous disease in Japan with special reference to gp91-phox and p22-phox deficiency."Human Genetics. 106(5). 473-481 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Yoshikazu Sugimoto, Satomi Tsukahara, Shigeo Sato, Mutsumi Suzuki, Hiroyuki Nunol, Harry L. Malech, Michael M. Gottesman., Takhashi Tsuruo.: "Drug-selected co-expression of P-glycoprotien and gp91 in vivo from an MDR1-bicistronic retrovirus vector Ha-MDR-IRES-gp91"Journal of gene Medicine. 4(in Press). (2003)

    • Related Report
      2002 Annual Research Report
  • [Publications] 布井博幸, 林摩耶, 早見典子, 原田優, 林幹夫, 広瀬真次, 松本栄悠丁, 水間洋, 日高文郎, 外山誠也, 水上智之: "小児免疫不全"臨床と研究. 79巻8号. 1404-1410 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Kuribayashi F, Nunoi H, Wakamatsu K, Tsunawaki S, Sato K, Ito T, Sumimoto H: "The adaptor protein p40(phox) as a positive regulator of the superoxide-producing phagocyte oxidase"The EMBO Journal. 21.23. 6312-6320 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Ishibashi F, Mizukami T, Kanegasaki S, Motoda L, Kakinuma R, Endo F, Nunoi N.: "Improved superoxide generating ability by interferon-gamma due to splicing pattern change of transcripts in neutrophils from patients with a splice site mutation in CYBB gene"Blood. 98・2. 436-441 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Nunoi H, Yamazaki T, Kanegasaki S, Neutrophil cytoskeletal disease.: "Neutrophi1 cytoskeletal disease"Int J Hematol.. 74・2. 119-124 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Cui SH, Tanabe F, Terunuma H, Iwatani Y, Nunoi H, Agematsu K, Kumiyama A, Nomura A, Hara T, Onodera T, Iwata T, Ito M.: "A thiol proteinase inhibitor, E-64-d, corrects the abnormalities in concanavalin A cap formation and the lysosomal enzyme activity in leucocytes from patients with Chediak-Higashi syndrome by reversing the down-regulated protein kinase C activity"Clin Exp Immunol.. 125・2. 283-290 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Yamauchi A, Yu L, Potgens AJ, Kuribayashi F, Nunoi H, Kanegasaki S, Roos D, Malech HL, Dinauer MC, Nakamura M.: "Location of the epitope for 7D5, a monoclonal antibody raised against human flavocytochrome b558, to the extracellular peptide porion of primate gp91phox"Microbiol Immunol.. 45・3. 249-257 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] 布井博幸, 水上智之, イジナ・マルカド, 三渕浩, 西原重剛, 後藤善降, 緒方敬之, 森島恒雄, 中山慎一, 森信二, 坂田宏, 森裕美, 真鍋孝治, 足立尚登, 遠藤文夫, 渡辺啓祐: "インフルエンザ感染症における重症度判定のためのマーカーの検討"インフルエンザ感染症における重症度判定のためのマーカーの検討. 13・3. 225-232 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Ishibashi F: "Statistical and mutational analysis of chronic granulomatous disease in Japan with special reference to gp91-phox and p22-phox deficiency.."Human Genetics.. 106. 473-481 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] 吉本寿美: "Dyskeratosis congenita患者の遺伝子解析"臨床血液. 41. 524-529 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] 水上智之: "慢性肉芽腫症の病因・病態と治療"小児内科. 32. 2032-2035 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] 布井博幸: "好中球アクチン機能異常症(好中球細胞骨格異常症)"日本臨床 領域別症候群シリーズ. 32. 146-149 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Ishibashi F: "Improved superoxide generating ability by interferon-gamma due to splicing pattern change of transcripts in neutrophils from patients with a splice site mutation in CYBB gene."Blood. (In press). (2001)

    • Related Report
      2000 Annual Research Report

URL: 

Published: 2000-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi